Lilly Releases Zepbound Single-Dose Vials for Adults Living with Obesity
Eli Lilly and Company released Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for adults living with obesity, and announced the medicines are available for self-pay for…
Read more Lilly Releases Zepbound Single-Dose Vials for Adults Living with Obesity